Free Trial

Teacher Retirement System of Texas Sells 13,599 Shares of CME Group Inc. (NASDAQ:CME)

→ Kiss of death from Joe Biden (From Porter & Company) (Ad)

Teacher Retirement System of Texas lowered its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 8.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 145,485 shares of the financial services provider's stock after selling 13,599 shares during the period. Teacher Retirement System of Texas' holdings in CME Group were worth $30,639,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. OFI Invest Asset Management acquired a new stake in shares of CME Group in the 3rd quarter worth $25,000. Northwest Financial Advisors acquired a new position in CME Group during the fourth quarter worth about $28,000. Harbor Investment Advisory LLC increased its holdings in CME Group by 966.7% in the fourth quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider's stock valued at $34,000 after buying an additional 145 shares in the last quarter. BKM Wealth Management LLC acquired a new stake in shares of CME Group during the 4th quarter valued at approximately $38,000. Finally, Atticus Wealth Management LLC purchased a new stake in shares of CME Group during the 3rd quarter worth approximately $40,000. Institutional investors and hedge funds own 87.75% of the company's stock.

CME Group Price Performance

Shares of NASDAQ:CME traded down $5.15 on Friday, hitting $208.46. The company had a trading volume of 1,838,846 shares, compared to its average volume of 1,817,135. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 52-week low of $175.73 and a 52-week high of $223.80. The business has a 50 day moving average of $213.11 and a 200 day moving average of $211.40. The company has a market cap of $75.04 billion, a PE ratio of 23.72, a PEG ratio of 5.34 and a beta of 0.48.


CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.44 by $0.06. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The firm had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.48 billion. During the same period in the prior year, the business posted $2.42 earnings per share. The firm's revenue for the quarter was up 3.2% compared to the same quarter last year. As a group, equities analysts anticipate that CME Group Inc. will post 9.72 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Friday, June 7th will be given a dividend of $1.15 per share. The ex-dividend date of this dividend is Friday, June 7th. This represents a $4.60 annualized dividend and a yield of 2.21%. CME Group's dividend payout ratio (DPR) is presently 52.33%.

Insider Buying and Selling

In other CME Group news, CEO Terrence A. Duffy sold 40,000 shares of the company's stock in a transaction dated Monday, April 29th. The stock was sold at an average price of $210.91, for a total transaction of $8,436,400.00. Following the completion of the sale, the chief executive officer now directly owns 67,455 shares in the company, valued at $14,226,934.05. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other CME Group news, insider Hilda Harris Piell sold 7,140 shares of the company's stock in a transaction dated Wednesday, May 8th. The stock was sold at an average price of $210.35, for a total transaction of $1,501,899.00. Following the completion of the sale, the insider now directly owns 29,256 shares in the company, valued at $6,153,999.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Terrence A. Duffy sold 40,000 shares of the stock in a transaction dated Monday, April 29th. The shares were sold at an average price of $210.91, for a total value of $8,436,400.00. Following the completion of the sale, the chief executive officer now owns 67,455 shares of the company's stock, valued at approximately $14,226,934.05. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Keefe, Bruyette & Woods lifted their price objective on CME Group from $222.00 to $226.00 and gave the stock a "market perform" rating in a report on Thursday, April 25th. Bank of America boosted their target price on CME Group from $209.00 to $216.00 and gave the stock a "neutral" rating in a research report on Thursday, April 25th. Barclays boosted their target price on CME Group from $226.00 to $228.00 and gave the stock an "equal weight" rating in a research report on Thursday, April 25th. JPMorgan Chase & Co. boosted their target price on CME Group from $198.00 to $206.00 and gave the stock a "neutral" rating in a research report on Thursday, April 25th. Finally, Rosenblatt Securities reiterated a "sell" rating and set a $187.00 target price (up from $185.00) on shares of CME Group in a research report on Thursday, April 25th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, CME Group currently has an average rating of "Hold" and a consensus target price of $217.80.

Read Our Latest Report on CME

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)

Should you invest $1,000 in CME Group right now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Featured Articles and Offers

Micron Stock is the NVIDIA of Memory

Micron Stock is the NVIDIA of Memory

Micron is at an inflection point for the business and the stock price. End-market inventory normalization and AI have allowed the company to return to growth, with growth accelerating to 50% last quar

Search Headlines: